295 related articles for article (PubMed ID: 17162559)
1. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell carcinoma: report of 10 cases and review of the literature.
Akhtar S; Oza KK; Wright J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.
Veness MJ; Perera L; McCourt J; Shannon J; Hughes TM; Morgan GJ; Gebski V
ANZ J Surg; 2005 May; 75(5):275-81. PubMed ID: 15932436
[TBL] [Abstract][Full Text] [Related]
4. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
Poulsen MG; Rischin D; Porter I; Walpole E; Harvey J; Hamilton C; Keller J; Tripcony L
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):114-9. PubMed ID: 16125873
[TBL] [Abstract][Full Text] [Related]
5. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Papadimitrakopoulou VA; Ginsberg LE; Garden AS; Kies MS; Glisson BS; Diaz EM; Clayman G; Morrison WH; Liu DD; Blumenschein G; Lippman SM; Schommer D; Gillenwater A; Goepfert H; Hong WK
Cancer; 2003 Nov; 98(10):2214-23. PubMed ID: 14601092
[TBL] [Abstract][Full Text] [Related]
6. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
Poulsen M; Rischin D; Walpole E; Harvey J; Mackintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L;
J Clin Oncol; 2003 Dec; 21(23):4371-6. PubMed ID: 14645427
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group.
Pectasides D; Papaxoinis G; Pectasides E; Galani H; Razi E; Katodrytis N; Fountzilas G; Economopoulos T
Oncology; 2007; 72(3-4):211-8. PubMed ID: 18176086
[TBL] [Abstract][Full Text] [Related]
8. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
9. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
Duprat JP; Domingues AL; Coelho EG; Leal RM; Nishinari K; Neves RI
Eur J Surg Oncol; 2009 Jun; 35(6):568-72. PubMed ID: 19013049
[TBL] [Abstract][Full Text] [Related]
10. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
13. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Schlemmer M; Wendtner CM; Falk M; Abdel-Rahman S; Licht T; Baumert J; Straka C; Hentrich M; Salat C; Hiddemann W; Issels RD
Oncology; 2006; 71(1-2):32-9. PubMed ID: 17344669
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
Tan EH; Ang PT
Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: a case series of twelve patients and review of the literature.
Samonis G; Mantadakis E; Kononas TC; Rigatos SK; Stathopoulos GP
Anticancer Res; 2001; 21(6A):4173-7. PubMed ID: 11911314
[TBL] [Abstract][Full Text] [Related]
18. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
19. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
